German licensed pharmaceutical distributor seeks outright divestiture for €250,000 OBO
An opportunity to acquire a fully licensed German pharmaceutical distributor purpose-built for the medical cannabis sector. The company operates under a lean, light-touch model leveraging outsourced logistics, compliance, and quality management partners, providing an efficient and scalable foundation for rapid market entry
Listing ID:
14916332561
Licence(s) Held:
Distribution (GDP) Licence and Wholesale Authorization (MedCanG)
Seeking outright divestiture of the licences for €250,000 o.b.o
Listing Details:
Fully licensed German medical cannabis wholesaler authorized to register, distribute, and sell medical cannabis products
Clean corporate structure, pre-revenue, no debt, and is currently fully licensed
Contracts in place with a licensed warehouse and logistics company for storage and distribution
Appointed Responsible Person for releasing narcotic and medical cannabis products, willing to stay on
Obtaining these licences typically requires 12–18 months, providing an immediate time-to-market advantage for an acquirer
Ideal for international producers, distributors, or investors seeking a compliant, plug-and-play platform to establish operations in Germany or the broader EU market
14916332561
NEW CANNABIS BUSINESSES FOR SALE
See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.
28790904174
Licensed 8,500 ft² Cannabis Cultivation & Nursery Facility on 23 Acres Near Montreal, QC for $1.7M OBO
Opportunity to acquire a fully built-out, cannabis cultivation buildings located 30 minutes east of Montreal, featuring two purpose-built cultivation and nursery buildings on 23 acres for 1.7M o.b.o
44498920359
Early-Stage UK Medical Cannabis Platform – Licensed Market Entry Opportunity
Unique opportunity to invest in a pre-operational UK medical cannabis platform being established through a structured regulatory and licensing pathway, led by an experienced sector operator and set to operate all steps from import to patient.
54492796721
Profitable German direct-to-patient medical cannabis platform for €1.95M OBO — €3M+ revenue, 25% profit contribution, fully operational asset package
Unique opportunity to acquire a fully operational, profitable e-health platform serving medical cannabis patients across Germany through an integrated online consultation, prescription, and pharmacy fulfilment model.